MiNK Therapeutics Statistics Share Statistics MiNK Therapeutics has 3.99M
shares outstanding. The number of shares has increased by 0.8%
in one year.
Shares Outstanding 3.99M Shares Change (YoY) 0.8% Shares Change (QoQ) 0.49% Owned by Institutions (%) 0.04% Shares Floating 990.98K Failed to Deliver (FTD) Shares 69,394 FTD / Avg. Volume 7.02%
Short Selling Information The latest short interest is 250.9K, so 6.3% of the outstanding
shares have been sold short.
Short Interest 250.9K Short % of Shares Out 6.3% Short % of Float 24.29% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.42 and the forward
PE ratio is -5.13.
MiNK Therapeutics's PEG ratio is
0.04.
PE Ratio -2.42 Forward PE -5.13 PS Ratio 0 Forward PS 390 PB Ratio -1.33 P/FCF Ratio -2.73 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MiNK Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.72,
with a Debt / Equity ratio of -0.25.
Current Ratio 0.72 Quick Ratio 0.72 Debt / Equity -0.25 Debt / EBITDA -0.47 Debt / FCF -0.52 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-468.9K Employee Count 23 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -10.77B Effective Tax Rate 99900%
Stock Price Statistics The stock price has increased by 46.47% in the
last 52 weeks. The beta is 0.33, so MiNK Therapeutics's
price volatility has been higher than the market average.
Beta 0.33 52-Week Price Change 46.47% 50-Day Moving Average 13.15 200-Day Moving Average 9.17 Relative Strength Index (RSI) 44.18 Average Volume (20 Days) 987,872
Income Statement
Revenue n/a Gross Profit n/a Operating Income -10.65M Net Income -10.78M EBITDA -10.57M EBIT -10.78M Earnings Per Share (EPS) -2.9
Full Income Statement Balance Sheet The company has 4.58M in cash and 4.92M in
debt, giving a net cash position of -347.57K.
Cash & Cash Equivalents 4.58M Total Debt 4.92M Net Cash -347.57K Retained Earnings -144.18B Total Assets 4.27M Working Capital -8.54M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.56M
and capital expenditures 0, giving a free cash flow of -9.56M.
Operating Cash Flow -9.56M Capital Expenditures n/a Free Cash Flow -9.56M FCF Per Share -2.55
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields INKT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for INKT is $37.5,
which is 206.6% higher than the current price. The consensus rating is "Hold".
Price Target $37.5 Price Target Difference 206.6% Analyst Consensus Hold Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 28, 2025. It was a
backward
split with a ratio of 1:10.
Last Split Date Jan 28, 2025 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -54.93 Piotroski F-Score 3
